Charles River Laboratories International Inc (CRL)
187.91
-1.85
(-0.97%)
USD |
NYSE |
Jan 08, 16:00
187.93
+0.02
(+0.01%)
After-Hours: 20:00
Charles River Laboratories International Shareholders Equity (Quarterly): 3.782B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| CVS Health Corp | 74.94B |
| Haemonetics Corp | 878.85M |
| Arbutus Biopharma Corp | 106.89M |
| FibroBiologics Inc | 2.737M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.004B |
| Total Liabilities (Quarterly) | 4.176B |
| Debt to Equity Ratio | 0.6151 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 0.70% |